You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

O-6-methylguanine-DNA methyltransferase

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Glioblastoma Multiforme of Brain Trial (biological, procedure, radiation, drug)

Not yet recruiting
  • Glioblastoma Multiforme of Brain
  • TVI-Brain-1
  • +3 more
  • (no location specified)
Jan 13, 2023

Colorectal Cancer Trial in New Haven (Temozolomide + Olaparib)

Active, not recruiting
  • Colorectal Cancer
  • Temozolomide + Olaparib
  • New Haven, Connecticut
    Yale New Haven Hospital
Aug 17, 2022

O6-methylguanine-DNA Methyltransferase Promoter Methylation and

Active, not recruiting
  • Sarcoma
  • O6-methylguanine-DNA methyltransferase (MGMT) promoter methylation and MGMT expression on dacarbazine treated sarcoma patients
  • Naples, Campania, Italy
    National Cancer Institute of Naples
May 14, 2021

Neuroendocrine Tumors Trial in France (Oxaliplatin-based chemo, Alkylating-based chemo)

Active, not recruiting
  • Neuroendocrine Tumors
  • Oxaliplatin-based chemotherapy
  • Alkylating-based chemotherapy
  • Amiens, France
  • +18 more
Mar 15, 2022

Advanced Rectal Cancer Trial in Seoul (Capecitabine plus temozolomide VS Capecitabine)

Unknown status
  • Advanced Rectal Cancer
  • Capecitabine plus temozolomide VS Capecitabine
  • Seoul, Songpa, Korea, Republic of
    Asan Medical Center
Jan 17, 2021

Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Guangzhou (VAL-083 (Dianhydrogalactitol))

Active, not recruiting
  • Glioma
  • +4 more
  • VAL-083 (Dianhydrogalactitol)
  • Guangzhou, China
    Sun Yat-Sen University Cancer Center
Mar 23, 2022

Glioblastoma, Adult Trial in United States (Paxalisib (GDC-0084))

Active, not recruiting
  • Glioblastoma, Adult
  • Paxalisib (GDC-0084)
  • Los Angeles, California
  • +5 more
Aug 16, 2022

Neuroendocrine Tumors, Frailty, Chemo Effect Trial in Milan (Temozolomide capsule)

Recruiting
  • Neuroendocrine Tumors
  • +2 more
  • Temozolomide capsule
  • Milan, Italy
    European Institute of Oncology, IEO, IRCCS
Sep 21, 2022

Colorectal Tumors, Microsatellite Instability Trial in Milano, Rozzano (temozolomide (induction),, pembrolizumab (treatment))

Recruiting
  • Colorectal Neoplasms
  • Microsatellite Instability
  • temozolomide (induction),
  • pembrolizumab (treatment)
  • Milano, Italy
  • +3 more
Sep 28, 2022

Glioblastoma Multiforme, Adult Trial (Integrated boost technique (SIB) guided by PET FDOPA)

Not yet recruiting
  • Glioblastoma Multiforme, Adult
  • Integrated boost technique (SIB) guided by PET FDOPA
  • (no location specified)
Dec 7, 2022

Brain Cancer Trial in Worldwide (Nivolumab, Temozolomide, Radiotherapy)

Completed
Has Results
  • Brain Cancer
  • Birmingham, Alabama
  • +124 more
Mar 16, 2022

Rectal Cancer Trial in Milan (External-beam radiation, Capecitabine, Temozolomide)

Recruiting
  • Rectal Cancer
  • External-beam radiation
  • +2 more
  • Milan, Italy
    Fondazione IRCCS Istituto Nazionale dei Tumori
Jan 25, 2022

Advanced Malignant Solid Tumor, Hematopoietic and Lymphoid System Tumor, Metastatic Malignant Solid Tumor Trial (Biopsy,

Not yet recruiting
  • Advanced Malignant Solid Neoplasm
  • +2 more
  • Biopsy
  • +5 more
  • (no location specified)
Jan 18, 2023

Glioblastoma, Glioma, Malignant Trial in Durham (MT-201-GBM monocyte vaccine)

Not yet recruiting
  • Glioblastoma
  • Glioma, Malignant
  • MT-201-GBM monocyte vaccine
  • Durham, North Carolina
    The Preston Robert Tisch Brain Tumor Center at Duke University M
May 25, 2022

Cytochrome C Oxidase Activity in Newly Diagnosed Glioblastoma

Active, not recruiting
  • Glioblastoma
    • Birmingham, Alabama
    • +18 more
    Mar 7, 2022

    Glioma, Glioblastoma, Glioblastoma Multiforme Trial in Houston (VAL-083, Dianhydrogalactitol)

    Active, not recruiting
    • Glioma
    • +4 more
    • VAL-083, Dianhydrogalactitol
    • Houston, Texas
      University of Texas MD Anderson Cancer Center
    Mar 23, 2022

    Glioblastoma Multiforme, Adult Trial in Worldwide (Berubicin, Lomustine)

    Recruiting
    • Glioblastoma Multiforme, Adult
    • Phoenix, Arizona
    • +49 more
    Aug 17, 2022

    Glioblastoma Trial in Cleveland (Ibrutinib, Radiation, Temozolomide (TMZ))

    Active, not recruiting
    • Glioblastoma
    • Cleveland, Ohio
      Cleveland Clinic Taussig Cancer Institute, Case Comprehensive Ca
    Jan 30, 2023

    Recurrent IDH1/2 Mutated Glioma Trial in Paris (Azacitidine)

    Recruiting
    • Recurrent IDH1/2 Mutated Glioma
    • Paris, France
      Pitie Salpetriere Hospital
    Aug 29, 2022

    Gastrinoma, Glucagonoma, Insulinoma Trial in Stanford (Capecitabine, Temozolomide, Bevacizumab)

    Completed
    Has Results
    • Gastrinoma
    • +8 more
    • Stanford, California
      Stanford University Medical Center
    Apr 8, 2021

    Colorectal Cancer Trial (Irinotecan, Temozolomide)

    Not yet recruiting
    • Colorectal Cancer
    • (no location specified)
    Apr 1, 2022

    Metastatic Colorectal Cancer Trial in Milan (Temozolomide, Nivolumab, Ipilimumab)

    Completed
    • Metastatic Colorectal Cancer
    • Milan, MI, Italy
      Fondazione IRCCS Istituto Nazionale dei Tumori
    Apr 1, 2022

    Glioblastoma Trial in Spain (Temozolomide)

    Completed
    Has Results
    • Glioblastoma
    • Badalona, Barcelona, Spain
    • +19 more
    Dec 17, 2020

    Glioblastoma Trial run by the NCI (drug, biological, other)

    Completed
    • Glioblastoma
    • Bethesda, Maryland
      National Institutes of Health Clinical Center
    Dec 23, 2022

    6 Months Adjuvant Temozolomide vs No Adjuvant TMZ in Newly

    Withdrawn
    • MGMT-Methylated Glioblastoma
    • Delay of TMZ
    • Standard of Care (SOC) Adjuvant TMZ (no intervention
    • (no location specified)
    Aug 5, 2022